DaVita HealthCare Partners Inc (DVA)vsCharming Medical Limited Class A Ordinary Shares (MCTA)
DVA
DaVita HealthCare Partners Inc
$192.16
-0.01%
HEALTHCARE · Cap: $13.39B
MCTA
Charming Medical Limited Class A Ordinary Shares
$29.36
0.00%
HEALTHCARE · Cap: $504.26M
Smart Verdict
WallStSmart Research — data-driven comparison
DaVita HealthCare Partners Inc generates 255009% more annual revenue ($13.84B vs $5.42M). MCTA leads profitability with a 12.1% profit margin vs 5.7%. DVA trades at a lower P/E of 20.1x. DVA earns a higher WallStSmart Score of 70/100 (B-).
DVA
Strong Buy70
out of 100
Grade: B-
MCTA
Avoid27
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-17.0%
Fair Value
$123.34
Current Price
$192.16
$68.82 premium
Intrinsic value data unavailable for MCTA.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 81 in profit
Conservative balance sheet, low leverage
Growing faster than its price suggests
Earnings expanding 43.5% YoY
Earnings expanding 81.0% YoY
Areas to Watch
5.7% margin — thin
Weak financial health signals
Distress zone — elevated risk
Distress zone — elevated risk
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : DVA
The strongest argument for DVA centers on Return on Equity, Debt/Equity, PEG Ratio. PEG of 0.65 suggests the stock is reasonably priced for its growth.
Bull Case : MCTA
The strongest argument for MCTA centers on EPS Growth.
Bear Case : DVA
The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.
Bear Case : MCTA
The primary concerns for MCTA are Altman Z-Score, Market Cap, Return on Equity. A P/E of 419.4x leaves little room for execution misses. Debt-to-equity of 23.57 is elevated, increasing financial risk.
Key Dynamics to Monitor
DVA profiles as a value stock while MCTA is a declining play — different risk/reward profiles.
DVA is growing revenue faster at 6.0% — sustainability is the question.
DVA generates stronger free cash flow (219M), providing more financial flexibility.
Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
DVA scores higher overall (70/100 vs 27/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DaVita HealthCare Partners Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
Charming Medical Limited Class A Ordinary Shares
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Charming Medical Limited, engage in the provision of beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong. The company is headquartered in Causeway Bay, Hong Kong.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?